Anal squamous cell carcinoma – Diagnostics – Overview of Information and Clinical Research

Understanding how anal squamous cell carcinoma is diagnosed can help you know when to seek medical attention and what to expect during the evaluation process. Early detection plays a crucial role in treatment success, yet many people delay seeing a healthcare provider because symptoms can seem similar to common, less serious conditions.

Introduction: Who Should Undergo Diagnostics

If you notice any unusual symptoms in or around your anal area, it’s important to schedule a visit with a healthcare provider. Many people hesitate to seek help because anal symptoms can feel embarrassing or because they assume the problem is something minor like hemorrhoids. However, early diagnosis of anal squamous cell carcinoma significantly improves the chances of successful treatment.^[1]

You should consider seeing a healthcare provider if you experience rectal bleeding or bloody stools, especially if this is the most common warning sign. Other symptoms that warrant medical attention include pain or a feeling of fullness in the anal area that makes you feel like you constantly need to have a bowel movement. Changes in your bowel habits, such as noticing that your stools have become thinner than usual, should also prompt a visit to your doctor.^[1]

Additional signs that require evaluation include finding a lump or mass at your anal opening, or experiencing persistent itching in the anal area. The important thing to remember is that having one or more of these symptoms doesn’t automatically mean you have cancer. Many common conditions, such as hemorrhoids (swollen blood vessels in the rectum or anus), can cause similar symptoms. However, you shouldn’t wait to see if symptoms improve on their own for more than a few days.^[1]

People who have certain risk factors may benefit from screening even without symptoms. If you have multiple risk factors for anal cancer, such as infection with the human papillomavirus (HPV, a common virus spread through sexual contact), HIV (a virus that weakens the immune system), or a weakened immune system from other causes, talk to your healthcare provider about whether screening tests would be appropriate for you. Healthcare providers don’t routinely screen everyone for anal cancer, but those at higher risk might benefit from tests like an anal pap test or anal HPV test, especially since anal cancer doesn’t always cause symptoms in the early stages.^[1]

⚠️ Important

Patients with anal cancer often delay seeking medical care, and the condition is sometimes misdiagnosed or the diagnosis is significantly delayed while the patient receives treatment for other benign conditions like hemorrhoids. To avoid diagnostic delay, it’s important to refer patients with persistent or unusual anal symptoms to a specialist.^[3]

Classic Diagnostic Methods

When you visit a healthcare provider with symptoms that might suggest anal cancer, they will use several methods to examine you and determine whether cancer is present. The diagnostic process typically begins with a physical examination and progresses to more detailed tests if needed.

Physical Examination

The first step in diagnosing anal squamous cell carcinoma is usually a digital rectal exam. During this examination, a healthcare professional inserts a gloved, lubricated finger into your anus to feel the anal canal and rectum for any growths or other signs that might indicate cancer. While this may sound uncomfortable, it’s a quick and important way for your doctor to detect abnormalities. The provider will also carefully examine your inguinal region (the area where your legs meet your torso) and check for any enlarged lymph nodes that might suggest the cancer has spread.^[12]^[17]

Anoscopy

If the physical exam raises concerns, the next step is often an anoscopy. During this procedure, a healthcare professional inserts a thin, flexible tube with a light, called an anoscope, through the anal canal and into the rectum. The anoscope has a lens that allows the provider to examine the inside of your anal canal closely and look for any suspicious areas. This visual examination can reveal growths, abnormal tissue, or other changes that might indicate cancer.^[12]

For people at higher risk of anal cancer, a more detailed version called high-resolution anoscopy may be used. This specialized technique provides a clearer, magnified view of the anal canal and can help detect precancerous changes or early-stage cancer. High-resolution anoscopy is particularly useful for monitoring patients with risk factors, as it can identify problems before they develop into invasive cancer.^[3]^[17]

Biopsy

If your healthcare provider identifies any suspicious areas during the anoscopy or physical exam, they will need to take a sample of tissue for laboratory testing. This procedure is called a biopsy. The tissue sample is often collected during the anoscopy using special tools that can pass through the anoscope. Sometimes a fine-needle aspiration biopsy or core biopsy may be performed, where a thin needle is used to remove cells or a small piece of tissue from the suspicious area.^[12]^[17]

The tissue sample is then sent to a laboratory where specialists examine it under a microscope to determine if cancer cells are present. These laboratory tests can also identify what type of cancer it is and provide additional information through special tests that give more details about the cancer cells. Most anal cancers are squamous cell carcinomas, meaning they develop in the flat cells that line the anal canal. Your healthcare team uses all this information from the biopsy to create an appropriate treatment plan.^[12]

Imaging Tests

Once cancer is diagnosed, imaging tests help your healthcare team understand the location and size of the cancer and whether it has spread to other parts of your body. These tests create detailed pictures of the inside of your body without requiring surgery.

Computed tomography (CT) scans use X-rays taken from different angles and combine them with computer processing to create cross-sectional images of your body. CT scans can show the cancer and help evaluate whether it has spread to nearby lymph nodes or other organs.^[12]^[17]

Magnetic resonance imaging (MRI) uses powerful magnets and radio waves instead of X-rays to create detailed images of soft tissues in your body. MRI scans are particularly useful for evaluating the pelvic lymph nodes and understanding how far the cancer extends into surrounding tissues.^[12]^[17]

Ultrasound uses sound waves to create images of internal structures. In anal cancer diagnosis, ultrasound is sometimes performed through the rectum to get detailed images of the tumor and nearby structures.^[12]

Positron emission tomography (PET) scans may be used in some cases. During this test, a small amount of radioactive sugar is injected into your bloodstream. Cancer cells, which use more energy than normal cells, absorb more of this sugar and show up brighter on the scan. PET scans can help determine if cancer has spread to distant parts of the body.^[12]

X-rays may also be part of your diagnostic workup, providing quick images that can reveal certain abnormalities. All these imaging tests help your healthcare team stage your cancer, which means determining its extent and spread. This staging information is crucial for planning the most effective treatment approach.^[12]

Diagnostics for Clinical Trial Qualification

If you’re considering enrolling in a clinical trial for anal squamous cell carcinoma, you’ll need to undergo specific diagnostic tests that serve as standard criteria for determining whether you’re eligible to participate. Clinical trials have strict requirements to ensure patient safety and to produce reliable research results.

The basic diagnostic requirements for most clinical trials include confirmation of your diagnosis through histologic (microscopic tissue examination) testing. This means you must have a biopsy-proven diagnosis of anal squamous cell carcinoma. The pathology report from your biopsy, which describes the type and characteristics of your cancer cells, becomes a key document for trial eligibility.^[17]

Clinical trials typically require complete staging information, which means you’ll need imaging tests to determine the size of your tumor and whether it has spread. CT scans or MRI scans of your pelvis and abdomen are commonly required. These tests evaluate your pelvic lymph nodes and look for any signs that cancer has spread to other organs. Some trials may also require a PET scan to get additional information about cancer spread throughout the body.^[12]^[17]

If you have palpable (able to be felt) lymph nodes in your inguinal region, many clinical trials will require a biopsy of these nodes to confirm whether cancer has spread there. This information helps researchers understand the stage of your disease and whether you meet the specific criteria for the trial you’re considering.^[17]

Blood tests are another standard requirement for clinical trial participation. These tests assess your overall health and organ function to ensure you’re healthy enough to receive the experimental treatments being studied. Blood tests typically measure your blood cell counts, kidney function, liver function, and other markers of your general health status.

For trials studying treatments for patients with advanced or metastatic disease, additional imaging may be required to document all sites where cancer is present. This baseline documentation allows researchers to measure how well the treatment works by comparing images taken before, during, and after treatment.

Some clinical trials may have additional specific requirements. For example, trials studying treatments that target certain molecular characteristics of cancer cells might require special testing of your tumor tissue to look for those specific markers. If the trial is studying a treatment for recurrent anal cancer (cancer that has come back after previous treatment), documentation of your previous treatments and when the cancer recurred will be necessary.

It’s important to understand that meeting the diagnostic criteria is just one part of clinical trial eligibility. Trials also have criteria related to your overall health status, previous treatments you’ve received, and other medical conditions you may have. Your healthcare team can help you understand which clinical trials you might qualify for and what additional testing might be needed.

Prognosis and Survival Rate

Prognosis

The outlook for patients with anal squamous cell carcinoma depends largely on two major factors: the size of the tumor and whether cancer has spread to lymph nodes. Smaller tumors, particularly those less than 2 centimeters, tend to have better outcomes than larger ones. The location where cancer is first discovered also matters, with cancers caught before they spread having much better prognosis.^[10]

Anal cancer is usually curable, especially when it’s caught and treated early. At the time of diagnosis, most patients have what doctors call T1 or T2 disease, meaning tumors that are 5 centimeters or smaller. Fewer than 20 percent of patients have cancer that has already spread to lymph nodes when they’re first diagnosed. This is encouraging because early-stage disease responds well to treatment.^[10]

The way lymph nodes drain from the anal area follows the path of the inguinal vein. When you’re first evaluated for anal cancer, your healthcare provider will carefully examine your inguinal region (where your legs meet your torso) and take a biopsy of any lymph nodes they can feel. Whether cancer is found in these nodes significantly affects your prognosis. Even when cancer has spread to lymph nodes, however, many patients can still be successfully treated, as long as the cancer hasn’t invaded nearby organs or spread to distant parts of the body.^[10]

Since 1980, patients diagnosed with anal cancer have experienced significant improvements in survival. This improvement reflects advances in treatment approaches and better understanding of the disease. In Europe during the years 1983 to 1994, one-year survival increased from 78 percent to 81 percent, and five-year survival improved from 48 percent to 54 percent. These statistics show that treatments have become more effective over time.^[17]

Survival rate

For patients with early-stage anal squamous cell carcinoma—those with T1 or T2 tumors and no lymph node involvement—the five-year survival rate exceeds 85 percent. This means that more than 85 out of every 100 patients with early-stage disease are still alive five years after diagnosis. This high survival rate underscores the importance of early detection and treatment.^[10]

Even when anal cancer has spread to lymph nodes, the outlook remains hopeful for many patients. In cases where cancer is found in lymph nodes but hasn’t invaded adjacent organs or spread to distant sites in the body, five-year survival rates still exceed 50 percent. This means that more than half of patients with node-positive disease survive at least five years after diagnosis.^[10]

It’s important to remember that survival statistics are based on large groups of patients and represent averages. Individual outcomes depend on many factors, including the specific characteristics of your cancer, your overall health, how well you respond to treatment, and advances in medical care. Your healthcare team can give you more personalized information about your prognosis based on your specific situation.

#1 Clinical Trials Search in Europe